Cuba develops P32 chromic phosphate, a new arthritis drug to bypass U.S. embargo, helping patients avoid surgery and reduce chronic joint pain.
Cuba develops P32 chromic phosphate, a new arthritis drug to bypass U.S. embargo, helping patients avoid surgery and reduce chronic joint pain.
